We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

AbCheck and Pierre Fabre Enter into Strategic Research Partnership

News   Jun 19, 2015

 
AbCheck and Pierre Fabre Enter into Strategic Research Partnership
 
 
Advertisement
 

RELATED ARTICLES

Industrial-Scale Farming May Be Perpetuating Spread of Antibiotic Resistant Staphs Through Pigs and People

News

According to a study, multidrug-resistant Staphylococcus aureus strains are spreading between pigs, farmworkers, their families and community residents, which could represent an emerging public health threat.

READ MORE

NIH Closes Enrolment for Two Sub-Studies in ACTIV-3 Trial

News

The ACTIV-3 clinical trial, which is evaluating the safety and efficacy of investigational therapeutics for COVID-19 in hospitalized patients, has closed enrolment in two sub-studies. The first sub-study was examining the investigational monoclonal antibody therapy VIR-7831 and the second was evaluating a combined monoclonal antibody therapy containing BRII-196 and BRII-198.

READ MORE

Scientists Reprogram E. coli To Produce Designer Polysaccharide Molecule

News

For the first time, scientists have reprogrammed the bacterium Escherichia coli to produce chondroitin sulfate, a component of cartilage that is often used as a dietary supplement to treat osteoarthritis. Currently, the supplement is sourced from cow tracheas.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE